Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for cardiac arrest
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cardiac arrest or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on cardiac arrest and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
The association between hyperoxia and patient outcomes after cardiacarrest: analysis of a high-resolution database PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?
Massive haemorrhage from a haemofiltration line (Vascath) on returning from computed tomography, resulting in cardiacarrest: A coronerâ€™s request for dissemination 28979463 2017 10 05 1751-1437 17 1 2016 Feb Journal of the Intensive Care Society J Intensive Care Soc Massive haemorrhage from a haemofiltration line (Vascath) on returning from computed tomography, resulting in cardiacarrest: A coroner's request for dissemination. 82-83 10.1177/1751143715601123 Bigham Sarah S Intensive Care
Therapeutic hypothermia after out-of-hospital cardiacarrest in children 28979460 2018 11 13 1751-1437 17 1 2016 Feb Journal of the Intensive Care Society J Intensive Care Soc Therapeutic hypothermia after out-of-hospital cardiacarrest in children. 73-75 10.1177/1751143715623450 eng Journal Article Review 2016 01 05 England J Intensive Care Soc 101538668 1751-1437 2017 10 6 6 0 2016 2 1 0 0 2016 2 1 0 1 ppublish 28979460 10.1177/1751143715623450 10.1177_1751143715623450 PMC5606388 N Engl J Med
low-quality evidence). 11 5 Safety with Percutaneous Coronary Intervention? Five studies indicate that the combination of therapeutic hypothermia and primary percutaneous intervention was feasible and safe after cardiacarrest caused by acute myocardial infarction. 1 Recommendation ANZCOR suggests that percutaneous coronary intervention during TTM is feasible and safe and may be associated with improved outcome. 1 [Class B; LOE III-3, IV] ANZCOR suggests institutions or communities planning (...) . Castren M, Nordberg P, Svensson L, et al. Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study (PRINCE: Pre-ROSC Intra Nasal Cooling Effectiveness). Circulation 2010;122:729–36 13. Nagao K, Kikushima K, Watanabe K, et al. Early induction of hypothermia during cardiacarrest improves neurological outcomes in patients with out-of-hospital cardiacarrest who undergo emergency cardiopulmonary bypass and percutaneous coronary intervention. Circ J 2010;74:77–85.247. 14
of structural heart damage increasing at greater velocities. Suspected traumatic cardiacarrest due to commotio cordis should be managed according to the general principles for CPR outlined in ANZCOR Guideline 11.2, with early defibrillation of shockable rhythms accorded the same high priority (Class A; LOE IV). 7.2 Isolated major head injury Isolated traumatic brain injury (TBI) without substantial structural brain pathology has been noted in case series and animal models occasionally to cause apnoea (...) /hypokalaemia and other metabolic disorders, hypo/hyperthermia, tension pneumothorax, tamponade, toxins, and thrombosis – pulmonary / coronary) in any patient in cardiacarrest, particularly those in asystole. Following this cardiacarrest due to trauma guideline will identify and treat all these conditions, with the exceptions of hypo/hyperthermia, toxins and thrombosis. These relatively infrequent causes should be considered in a patient who has not responded to other interventions. (Class A, LOE IV
Atrio-Ventricular CA Collaborative Assessment CAD Coronary Artery Disease CABG Coronary Artery Bypass Grafting CE Conformité Européene CFDA China Food and Drug Administration CMR Cardiac Magnetic Resonance CPVT Cathecholaminergic Polymorphic Ventricular Tachycardia CT Controlled Trials CT Computed Tomography CRT-D Cardiac Resynchronisation Therapy CUR Health Problem and Current Use of the Technology domain d(s) day(s) ECG Electrocardiogram EFF Clinical Effectiveness domain EHRA European Heart Rhythm (...) Heart Association ORG Organisational aspects domain PM Pacemaker PMDA Pharmaceuticals and Medical Devices Agency PPCM Peripartum Cardiomyopathy pre-op pre-operation pt(s) patient(s) PVC Premature Ventricular Complex QoL Quality of Life REA Relative Effectiveness Assessment RCT Randomised Controlled Trials RVOT Right Ventricular Outflow Tract SA-ECG Signal-Averaged ECG SAE Serious Adverse Events SAF Safety domain SCA Sudden CardiacArrest SCD Sudden Cardiac Death SD Standard Deviation SPECT Single
Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiacarrest in patients at risk Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiacarrest in patients at risk Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiacarrest in patients at risk Ettinger S, Stanak M, Huić M, Hacek RT, Ercevic D, Grenkovic R, Wild C Record Status (...) This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Ettinger S, Stanak M, Huić M, Hacek RT, Ercevic D, Grenkovic R, Wild C. Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiacarrest in patients at risk. Vienna: Ludwig Boltzmann Institut fuer Health Technology Assessment (LBIHTA). Decision Support Document. 2016 Authors
. and Stanak, M. and Huić, M. and Hacek, R.T. and Ercevic, D. and Grenkovic, R. and Wild, C. (2016): Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiacarrest in patients at risk.. Decision Support Document 103. Preview - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. , oder 3MB Abstract Sudden cardiacarrest (SCA) is the most common cause of death in patients with coronary artery disease. In Europe, there are about 350 000 out (...) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiacarrest in patients at risk.. Decision Support Document 103. Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiacarrest in patients at risk. - Repository of AIHTA GmbH English | Browse - - - Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiacarrest in patients at risk. Ettinger, S
Warning Symptoms Are Associated With Survival From Sudden CardiacArrest. Survival after sudden cardiacarrest (SCA) remains low, and tools for improved prediction of patients at long-term risk for SCA are lacking. Alternative short-term approaches aimed at preemptive risk stratification and prevention are needed.To assess characteristics of symptoms in the 4 weeks before SCA and whether response to these symptoms is associated with better outcomes.Ongoing prospective population-based (...) %) called emergency medical services (911) to report symptoms before SCA; these persons were more likely to be patients with a history of heart disease (P < 0.001) or continuous chest pain (P < 0.001). Survival when 911 was called in response to symptoms was 32.1% (95% CI, 21.8% to 42.4%) compared with 6.0% (CI, 3.5% to 8.5%) in those who did not call (P < 0.001).Potential for recall and response bias, symptom assessment not available in 24% of patients, and missing data for some patients and SCA
Continuous or Interrupted Chest Compressions for CardiacArrest. 26552007 2015 12 23 2018 12 02 1533-4406 373 23 2015 Dec 03 The New England journal of medicine N. Engl. J. Med. Continuous or Interrupted Chest Compressions for CardiacArrest. 2278-9 10.1056/NEJMe1513415 Koster Rudolph W RW From the Department of Cardiology, Academic Medical Center, Amsterdam. eng Editorial Comment 2015 11 09 United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Dec 3;373(23):2203-14 26550795 (...) Cardiopulmonary Resuscitation methods Emergency Medical Services Female Humans Male Out-of-Hospital CardiacArrest therapy Positive-Pressure Respiration 2015 11 10 6 0 2015 11 10 6 0 2015 12 24 6 0 ppublish 26552007 10.1056/NEJMe1513415
The CAHP (CardiacArrest Hospital Prognosis) score: a tool for risk stratification after out-of-hospital cardiacarrest Survival after out-of-hospital cardiacarrest (OHCA) remains disappointingly low. Among patients admitted alive, early prognostication remains challenging. This study aims to establish a stratification score for patients admitted in intensive care unit (ICU) after OHCA, according to their neurological outcome.The CAHP (CardiacArrest Hospital Prognosis) score was developed (...) from the Sudden Death Expertise Center registry (Paris, France). The primary outcome was poor neurological outcome defined as Cerebral Performance Category 3, 4, or 5 at hospital discharge. Independent prognostic factors were identified using logistic regression analysis and thresholds defined to stratify low-, moderate-, and high-risk groups. The CAHP score was validated in both a prospective and an external data set (Parisian CardiacArrest Registry). The developmental data set included 819
[Pre-hospital ECMO for refractory cardiacarrest] ECMO pour la prise en charge pré-hospitalière de l'arrêt cardiaque [Pre-hospital ECMO for refractory cardiacarrest] ECMO pour la prise en charge pré-hospitalière de l'arrêt cardiaque [Pre-hospital ECMO for refractory cardiacarrest] Comite d´Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation (...) of the quality of this assessment has been made for the HTA database. Citation Comite d´Evaluation et de Diffusion des Innovations Technologiques (CEDIT). ECMO pour la prise en charge pré-hospitalière de l'arrêt cardiaque. [Pre-hospital ECMO for refractory cardiacarrest] Paris, France: Comite d´Evaluation et de Diffusion des Innovations Technologiques (CEDIT). 2015 Authors' objectives The CEDIT (hospital based HTA agency) of AP-HP (Paris University Hospital) assessed the impact and value of extracorporeal
Outcomes following out-of-hospital cardiacarrest: What is the potential for donation after circulatory death? We conducted a prospective observational study on 100 consecutive patients admitted to intensive care units at Leeds General Infirmary following out-of-hospital cardiacarrest. In the non-survivors, we reviewed their potential for organ donation via donation after circulatory death. Out of the 100 patients, 53 did not survive to hospital discharge. Out of these non-survivors, 13 died (...) very suddenly within the intensive care unit and 3 other patients subsequently died in a general ward following discharge from the intensive care unit. One patient became brainstem dead, with out-of-hospital cardiacarrest secondary to a subarachnoid haemorrhage, rather than a primary cardiac cause. This patient went on to donate via the brain death mode. The remaining 36 patients had treatment withdrawn in the intensive care unit. Of these, 29 were referred to the transplant team for potential
A good outcome after absence of bilateral N20 SSEPs post-cardiacarrest A 51-year-old man suffered a cardiacarrest after an attempted hanging. Post-arrest assessment revealed the bilateral absence of negative 20 somatosensory evoked potentials (N20 SSEPs) which is suggestive of a poor neurological outcome. Current evidence recommends its use in prognostication. Our patient made a good recovery which brings into question the value of negative 20 somatosensory evoked potentials
Management of cardiacarrest survivors in UK intensive care units: a survey of practice Cardiacarrest is a common presentation to intensive care units. There is evidence that management protocols between hospitals differ and that this variation is mirrored in patient outcomes between institutions, with standardised treatment protocols improving outcomes within individual units. It has been postulated that regionalisation of services may improve outcomes as has been shown in trauma, burns (...) and stroke patients, however a national protocol has not been a focus for research. The objective of our study was to ascertain current management strategies for comatose post cardiacarrest survivors in intensive care in the United Kingdom.A telephone survey was carried out to establish the management of comatose post cardiacarrest survivors in UK intensive care units. All 235 UK intensive care units were contacted and 208 responses (89%) were received.A treatment protocol is used in 172 units (82.7
Alignment of Do-Not-Resuscitate Status With Patients' Likelihood of Favorable Neurological Survival After In-Hospital CardiacArrest. After patients survive an in-hospital cardiacarrest, discussions should occur about prognosis and preferences for future resuscitative efforts.To assess whether patients' decisions for do-not-resuscitate (DNR) orders after a successful resuscitation from in-hospital cardiacarrest are aligned with their expected prognosis.Within Get With The Guidelines (...) -Resuscitation, we identified 26,327 patients with return of spontaneous circulation (ROSC) after in-hospital cardiacarrest between April 2006 and September 2012 at 406 US hospitals. Using a previously validated prognostic tool, each patient's likelihood of favorable neurological survival (ie, without severe neurological disability) was calculated. The proportion of patients with DNR orders within each prognosis score decile and the association between DNR status and actual favorable neurological survival
Association of presence and timing of invasive airway placement with outcomes after pediatric in-hospital cardiacarrest PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?
Association of Bystander Interventions With Neurologically Intact Survival Among Patients With Bystander-Witnessed Out-of-Hospital CardiacArrest in Japan. Neurologically intact survival after out-of-hospital cardiacarrest (OHCA) has been increasing in Japan. However, associations between increased prehospital care, including bystander interventions and increases in survival, have not been well estimated.To estimate the associations between bystander interventions and changes in neurologically (...) intact survival among patients with OHCA in Japan.Retrospective descriptive study using data from Japan's nationwide OHCA registry, which started in January 2005. The registry includes all patients with OHCA transported to the hospital by emergency medical services (EMS) and recorded patients' characteristics, prehospital interventions, and outcomes. Participants were 167,912 patients with bystander-witnessed OHCA of presumed cardiac origin in the registry between January 2005 and December 2012